🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study tests whether an asthma medication called dupilumab can help peo...
Status
Recruiting
Location
Sir Charles Gairdner Hospital
Start Date
2026-01-29
Trial ID
NCT07309614
Treatments Being Tested
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested
The primary objective of this Phase 2 study is to evaluate the efficacy and...
Status
Recruiting
Location
China-japan Friendship Hospital
Start Date
2026-02-06
Trial ID
NCT07399067
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested
The purpose of this study is to find a more effective treatment for allergi...
Status
Terminated
Location
Emory Hospital Midtown-Otolaryngology
Start Date
2023-10-26
Trial ID
NCT05545072
Treatments Being Tested
The goal of this clinical trial is to learn if dupilumab works to treat sev...
Status
Recruiting
Location
National University Hospital
Start Date
2025-11-27
Trial ID
NCT07091175
This study is researching a drug called dupilumab. The study is focused on ...
Status
Active Not Recruiting
Location
Kern Research, Inc
Start Date
2024-08-26
Trial ID
NCT06572228
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN...
Status
Completed
Location
Investigational Site Number 840047
Start Date
2015-04-27
Trial ID
NCT02414854
The main objective of the trial is to evaluate the efficacy of 2 dose regim...
Status
Completed
Location
Site 1
Start Date
2016-01-31
Trial ID
NCT02755649
Treatments Being Tested
The main objective of the trial is to demonstrate the efficacy of dupilumab...
Status
Completed
Location
Regeneron Research Site
Start Date
2017-11-17
Trial ID
NCT03345914